Insider Trading activities of Albany Molecular Research Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Albany Molecular Research Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Albany Molecular Research Inc since year 2005. Table 2 shows the detailed insider transactions of Albany Molecular Research Inc since 2005. The reporting company's ticker symbol is AMRI. The reporting company's CIK number is 1065087.
The total value of stock buying since 2005 is $7,517,422.
The total value of stock sales since 2005 is $26,434,114.
The total value of stock option exercises since 2005 is $1,708,365.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Albany Molecular Research Inc (AMRI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 0 $0 0 $0 15,000 $217,050
2016-11 0 $0 15,785 $265,570 9,000 $118,800
2016-10 0 $0 0 $0 5,000 $59,150
2016-08 0 $0 1,401 $21,421 0 $0
2016-05 25,000 $321,000 7,361 $102,199 10,000 $103,698
2015-11 0 $0 100,000 $1,960,000 0 $0
2015-08 0 $0 6,000 $125,750 6,000 $79,200
2015-06 10,000 $199,800 75,787 $1,496,858 5,000 $52,150
2015-05 0 $0 84,500 $1,580,107 14,500 $145,797
2015-04 0 $0 70,000 $1,256,270 22,367 $95,954
2015-03 30,000 $531,200 84,662 $1,466,464 10,000 $118,500
2015-02 0 $0 85,373 $1,417,189 13,750 $54,262
2015-01 0 $0 70,000 $1,142,751 0 $0
2014-12 0 $0 70,000 $1,129,646 0 $0
2014-11 30,000 $510,300 88,000 $1,669,095 18,000 $132,180
2014-10 0 $0 71,000 $1,534,460 0 $0
2014-09 0 $0 72,500 $1,432,700 0 $0
2014-08 0 $0 124,547 $2,365,447 51,250 $239,462
2014-07 0 $0 72,500 $1,519,120 0 $0
2014-06 0 $0 35,000 $575,124 2,500 $7,325
2014-05 40,000 $618,000 39,647 $626,487 6,250 $18,312
2014-04 0 $0 32,500 $602,449 0 $0
2014-03 0 $0 30,000 $462,600 0 $0
2014-02 0 $0 55,500 $745,085 27,500 $187,275
2013-12 30,000 $322,500 4,400 $50,125 2,500 $7,325
2013-11 20,000 $231,400 32,300 $418,365 0 $0
2013-10 0 $0 30,000 $385,500 0 $0
2013-09 0 $0 30,000 $360,000 0 $0
2013-08 0 $0 30,000 $375,900 0 $0
2013-07 0 $0 30,000 $374,100 0 $0
2013-06 10,000 $102,300 30,000 $360,000 0 $0
2013-05 0 $0 9,500 $103,763 7,500 $21,975
2013-03 0 $0 8,774 $90,531 0 $0
2013-02 0 $0 2,968 $23,988 0 $0
2012-12 10,000 $50,000 0 $0 0 $0
2012-11 20,000 $76,000 372 $1,305 0 $0
2012-08 0 $0 4,000 $12,220 0 $0
2012-06 0 $0 1,008 $2,298 0 $0
2012-05 200 $562 2,400 $7,223 0 $0
2012-03 0 $0 2,549 $7,037 0 $0
2011-12 23,900 $56,332 0 $0 0 $0
2011-11 0 $0 1,521 $4,542 0 $0
2011-05 0 $0 435 $2,105 0 $0
2011-03 0 $0 1,778 $7,515 0 $0
2010-12 0 $0 2,000 $10,400 0 $0
2010-11 0 $0 1,242 $7,278 0 $0
2010-03 0 $0 259 $2,286 0 $0
2009-11 0 $0 3,500 $29,015 0 $0
2009-08 0 $0 900 $7,910 0 $0
2009-02 0 $0 2,000 $20,980 0 $0
2008-11 0 $0 9,111 $100,294 0 $0
2008-02 1,000 $10,530 0 $0 0 $0
2007-12 2,000 $25,340 0 $0 0 $0
2007-11 7,218 $88,614 0 $0 0 $0
2007-09 0 $0 11,250 $172,642 11,250 $49,950
2006-10 1,268 $15,000 0 $0 0 $0
2006-06 2,500 $26,125 0 $0 0 $0
2005-05 5,904 $69,959 0 $0 0 $0
2005-03 508,866 $4,262,460 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Albany Molecular Research Inc insiders (AMRI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-26 Roth Arthur J (Director) Option Ex 5,000 14.47 72,350
2017-05-25 Oconnor Kevin (Director) Option Ex 5,000 14.47 72,350
2017-05-10 Ryan Una S (Director) Option Ex 5,000 14.47 72,350
2016-11-30 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 9,000 16.71 150,390
2016-11-30 Hagen Steven R (SVP Manufacturing & Pharmaceut) Option Ex 9,000 13.20 118,800
2016-11-16 Henderson Lori M. (SVP, Secretary & Gen Counsel) Sale 6,000 17.00 102,000
2016-11-10 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 785 16.79 13,180
2016-10-05 Ryan Una S (Director) Option Ex 5,000 11.83 59,150
2016-08-09 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 1,401 15.29 21,421
2016-05-31 Roth Arthur J (Director) Option Ex 5,000 10.37 51,849
2016-05-31 Oconnor Kevin (Director) Sale 5,000 14.41 72,050
2016-05-31 Oconnor Kevin (Director) Option Ex 5,000 10.37 51,849
2016-05-16 Marth William S (President and CEO) Buy 12,500 12.86 160,750
2016-05-13 Svokos George (Chief Operating Officer) Buy 12,500 12.82 160,250
2016-05-13 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 2,361 12.77 30,149
2015-11-09 D Ambra Thomas E (Director) Sale 50,000 19.60 980,000
2015-11-09 D Ambra Constance M (10% Owner) Sale 50,000 19.60 980,000
2015-08-17 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 1,000 20.45 20,450
2015-08-17 Hagen Steven R (SVP Manufacturing & Pharmaceut) Option Ex 1,000 13.20 13,200
2015-08-07 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 5,000 21.06 105,300
2015-08-07 Hagen Steven R (SVP Manufacturing & Pharmaceut) Option Ex 5,000 13.20 66,000
2015-06-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 19.77 395,400
2015-06-10 D Ambra Constance M Sale 20,000 19.77 395,400
2015-06-08 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 5,000 19.99 99,949
2015-06-08 Hagen Steven R (SVP Manufacturing & Pharmaceut) Option Ex 5,000 10.43 52,150
2015-06-04 Marth William S (President and CEO) Buy 10,000 19.98 199,800
2015-06-04 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 787 19.58 15,409
2015-06-01 Cable Stuart M Sale 30,000 19.69 590,700
2015-05-11 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 19.11 382,200
2015-05-11 D Ambra Constance M Sale 20,000 19.11 382,200
2015-05-08 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 14,500 19.27 279,487
2015-05-08 Hagen Steven R (SVP Manufacturing & Pharmaceut) Option Ex 14,500 10.05 145,797
2015-05-01 Cable Stuart M Sale 30,000 17.87 536,220
2015-04-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 18.50 370,000
2015-04-10 D Ambra Constance M Sale 20,000 18.50 370,000
2015-04-07 Marth William S (President and CEO) Option Ex 22,367 4.29 95,954
2015-04-01 Cable Stuart M Sale 30,000 17.21 516,270
2015-03-17 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 3,500 18.53 64,855
2015-03-13 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 441 18.79 8,286
2015-03-12 Roth Arthur J Sale 5,000 18.26 91,300
2015-03-12 Roth Arthur J Option Ex 5,000 11.85 59,250
2015-03-12 Oconnor Kevin Sale 5,000 18.22 91,100
2015-03-12 Oconnor Kevin Option Ex 5,000 11.85 59,250
2015-03-11 Hagen Steven R (SVP Manufacturing & Pharmaceut) Sale 721 18.30 13,194
2015-03-10 Svokos George (Chief Commercial Officer) Buy 10,000 17.72 177,200
2015-03-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 17.65 353,000
2015-03-10 D Ambra Constance M Sale 20,000 17.65 353,000
2015-03-05 Marth William S (President and CEO) Buy 20,000 17.70 354,000
2015-03-02 Cable Stuart M Sale 30,000 16.39 491,729
2015-02-25 Nolan Michael M (CFO) Sale 5,000 16.17 80,850
2015-02-25 Nolan Michael M (CFO) Option Ex 5,000 3.43 17,150
2015-02-23 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 3,750 16.22 60,824
2015-02-23 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 3,750 5.99 22,462
2015-02-18 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 6,623 16.51 109,365
2015-02-18 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 5,000 2.93 14,650
2015-02-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 16.91 338,200
2015-02-10 D Ambra Constance M Sale 20,000 16.91 338,200
2015-02-02 Cable Stuart M Sale 30,000 16.32 489,750
2015-01-12 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 16.45 329,000
2015-01-12 D Ambra Constance M Sale 20,000 16.45 329,000
2015-01-07 Cable Stuart M Sale 7,694 16.00 123,104
2015-01-05 Cable Stuart M Sale 22,306 16.21 361,647
2014-12-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 16.24 324,799
2014-12-10 D Ambra Constance M Sale 20,000 16.24 324,799
2014-12-05 Cable Stuart M Sale 13,307 16.00 212,938
2014-12-04 Cable Stuart M Sale 10,391 16.00 166,266
2014-12-03 Cable Stuart M Sale 6,302 16.00 100,844
2014-11-14 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 10,500 16.06 168,630
2014-11-14 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 10,500 8.31 87,255
2014-11-10 Marth William S (President and CEO) Buy 30,000 17.01 510,300
2014-11-10 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 7,500 17.03 127,725
2014-11-10 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 7,500 5.99 44,925
2014-11-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 17.07 341,400
2014-11-10 D Ambra Constance M Sale 20,000 17.07 341,400
2014-11-03 Cable Stuart M Sale 30,000 23.00 689,940
2014-10-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 21.62 432,400
2014-10-10 D Ambra Constance M Sale 20,000 21.62 432,400
2014-10-01 Cable Stuart M Sale 30,000 21.61 648,180
2014-10-01 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 1,000 21.48 21,480
2014-09-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 20.12 402,400
2014-09-10 D Ambra Constance M Sale 20,000 20.12 402,400
2014-09-02 Cable Stuart M Sale 30,000 19.30 579,000
2014-09-02 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 2,500 19.56 48,900
2014-08-28 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 1,250 19.74 24,674
2014-08-28 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 1,250 5.25 6,562
2014-08-14 Nolan Michael M (SVP, CFO and Treasurer) Sale 10,000 19.76 197,600
2014-08-14 Nolan Michael M (SVP, CFO and Treasurer) Option Ex 10,000 3.43 34,300
2014-08-12 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 30,000 19.05 571,500
2014-08-12 Henderson Lori M (SVP, Secretary & Gen. Counsel) Option Ex 30,000 4.87 146,100
2014-08-11 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 18.99 379,799
2014-08-11 D Ambra Constance M Sale 20,000 18.99 379,799
2014-08-08 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 10,797 18.99 205,035
2014-08-08 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 10,000 5.25 52,500
2014-08-01 Cable Stuart M Sale 30,000 18.69 560,640
2014-08-01 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 2,500 18.56 46,400
2014-07-10 D Ambra Thomas E Phd (Chairman, Board of Directors) Sale 20,000 20.94 418,800
2014-07-10 D Ambra Constance M Sale 20,000 20.94 418,800
2014-07-01 Cable Stuart M Sale 30,000 21.00 629,970
2014-07-01 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 2,500 20.62 51,550
2014-06-03 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 2,500 16.93 42,325
2014-06-03 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 2,500 2.93 7,325
2014-06-02 Cable Stuart M Sale 30,000 16.40 491,999
2014-06-02 Henderson Lori M (SVP, Secretary & Gen. Counsel) Sale 2,500 16.32 40,800
2014-05-16 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 1,250 15.45 19,312
2014-05-16 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 1,250 2.93 3,662
2014-05-15 Svokos George (SVP Sales & GM of API) Buy 10,000 15.60 156,000
2014-05-12 Marth William S (President and CEO) Buy 30,000 15.40 462,000
2014-05-12 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 2,500 15.27 38,175
2014-05-12 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 2,500 2.93 7,325
2014-05-09 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Sale 3,397 14.80 50,275
2014-05-09 Hagen Steven R (SVP Pharmaceutical Dev & Mfg) Option Ex 2,500 2.93 7,325
2014-05-01 Cable Stuart M Sale 30,000 15.98 479,400
2014-05-01 Henderson Lori M (VP, Secretary & Gen. Counsel) Sale 2,500 15.73 39,325
2014-04-01 Cable Stuart M Sale 30,000 18.52 555,600
2014-04-01 Henderson Lori M (VP, Secretary & Gen. Counsel) Sale 2,500 18.74 46,849
2014-03-03 Cable Stuart M Sale 30,000 15.42 462,600
2014-02-27 Roth Arthur J Sale 5,000 15.95 79,750
2014-02-27 Roth Arthur J Option Ex 5,000 12.85 64,250
2014-02-27 Oconnor Kevin Option Ex 5,000 12.85 64,250
2014-02-25 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 2,500 15.19 37,975
2014-02-25 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Option Ex 2,500 2.93 7,325
2014-02-24 Nolan Michael M (VP, CFO and Treasurer) Sale 15,000 15.00 225,000
2014-02-24 Nolan Michael M (VP, CFO and Treasurer) Option Ex 15,000 3.43 51,450
2014-02-21 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 1,500 14.87 22,305
2014-02-19 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 1,500 13.37 20,055
2014-02-13 Cable Stuart M Sale 30,000 12.00 360,000
2013-12-04 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 2,500 10.93 27,325
2013-12-04 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Option Ex 2,500 2.93 7,325
2013-12-03 Marth William S Buy 30,000 10.75 322,500
2013-12-02 Cable Stuart M Sale 1,900 12.00 22,800
2013-11-22 Marth William S Buy 20,000 11.57 231,400
2013-11-22 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 2,300 11.55 26,565
2013-11-01 Cable Stuart M Sale 30,000 13.06 391,800
2013-10-01 Cable Stuart M Sale 30,000 12.85 385,500
2013-09-13 Cable Stuart M Sale 30,000 12.00 360,000
2013-08-01 Cable Stuart M Sale 30,000 12.53 375,900
2013-07-01 Cable Stuart M Sale 30,000 12.47 374,100
2013-06-12 Cable Stuart M Sale 30,000 12.00 360,000
2013-06-03 Marth William S Buy 10,000 10.23 102,300
2013-05-29 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 800 11.26 9,008
2013-05-22 Sargent Bruce J (Sr VP, Drug Discovery) Sale 7,500 10.97 82,275
2013-05-22 Sargent Bruce J (Sr VP, Drug Discovery) Option Ex 7,500 2.93 21,975
2013-05-10 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 1,200 10.40 12,480
2013-03-19 Sargent Bruce J (Sr VP, Drug Discovery) Sale 258 9.91 2,556
2013-03-19 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 180 9.91 1,783
2013-03-18 Sargent Bruce J (Sr VP, Drug Discovery) Sale 256 9.98 2,554
2013-03-18 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 249 9.98 2,485
2013-03-13 Sargent Bruce J (Sr VP, Drug Discovery) Sale 852 10.69 9,107
2013-03-12 Sargent Bruce J (Sr VP, Drug Discovery) Sale 1,764 10.74 18,945
2013-03-12 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 677 10.75 7,277
2013-03-11 Sargent Bruce J (Sr VP, Drug Discovery) Sale 3,538 10.25 36,264
2013-03-07 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 1,000 9.56 9,560
2013-02-22 Sargent Bruce J (Sr VP, Drug Discovery) Sale 984 8.18 8,049
2013-02-22 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 984 8.18 8,049
2013-02-19 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 1,000 7.89 7,890
2012-12-03 Marth William S Buy 10,000 5.00 50,000
2012-11-15 D Ambra Thomas E Phd (Chairman, CEO & President) Buy 10,000 3.80 38,000
2012-11-15 D Ambra Constance M Buy 10,000 3.80 38,000
2012-11-05 Hagen Steven R (Sr VP Pharmaceutical Dev & Mfg) Sale 372 3.51 1,305
2012-08-24 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 1,000 3.22 3,220
2012-08-09 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 3,000 3.00 9,000
2012-06-05 Sargent Bruce J (Sr VP, Drug Discovery) Sale 504 2.28 1,149
2012-06-05 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 504 2.28 1,149
2012-05-22 Ryan Una S Buy 200 2.81 562
2012-05-15 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,400 3.01 7,223
2012-03-19 Sargent Bruce J (Sr VP, Drug Discovery) Sale 1,160 2.77 3,219
2012-03-19 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 1,078 2.77 2,991
2012-03-06 Sargent Bruce J (Sr VP, Drug Discovery) Sale 220 2.66 585
2012-03-06 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 91 2.66 242
2011-12-07 Leung Gabriel Buy 4,000 2.34 9,360
2011-12-07 Henderson Lori M (VP, general counsel) Buy 5,900 2.47 14,573
2011-12-06 Leung Gabriel Buy 4,000 2.45 9,800
2011-12-01 Frost Mark T (Chief Financial Officer) Buy 10,000 2.26 22,599
2011-11-14 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 382 2.62 1,000
2011-11-04 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 1,139 3.11 3,542
2011-05-06 Sargent Bruce J (Sr VP, Drug Discovery) Sale 237 4.84 1,147
2011-05-06 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 198 4.84 958
2011-03-18 Sargent Bruce J (Sr VP, Drug Discovery) Sale 863 4.18 3,607
2011-03-18 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 617 4.18 2,579
2011-03-07 Sargent Bruce J (Sr VP, Drug Discovery) Sale 211 4.46 941
2011-03-07 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 87 4.46 388
2010-12-06 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,000 5.20 10,400
2010-11-14 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 887 5.77 5,117
2010-11-10 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 355 6.09 2,161
2010-03-09 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 259 8.83 2,286
2009-11-19 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 1,500 8.05 12,075
2009-11-16 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,000 8.47 16,940
2009-08-06 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 900 8.79 7,910
2009-02-12 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,000 10.49 20,980
2008-11-20 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,400 8.96 21,504
2008-11-17 Hagen Steven R (VP Pharmaceutical Dev & Mfg) Sale 2,711 9.72 26,350
2008-11-05 D Ambra Thomas E Phd (Chairman, CEO & President) Sale 2,000 13.11 26,220
2008-11-05 D Ambra Constance M Sale 2,000 13.11 26,220
2008-02-15 Roth Arthur J Buy 1,000 10.53 10,530
2007-12-04 Roth Arthur J Buy 2,000 12.67 25,340
2007-11-20 Oconnor Kevin Buy 1,193 12.80 15,270
2007-11-19 Jordan Veronica Gh Buy 2,500 12.00 30,000
2007-11-16 Oconnor Kevin Buy 1,025 12.58 12,894
2007-11-09 Frost Mark T (Chief Financial Officer) Buy 2,500 12.18 30,450
2007-09-06 Tartaglia Anthony P Sale 11,250 15.35 172,642
2007-09-06 Tartaglia Anthony P Option Ex 11,250 4.44 49,950
2006-10-30 Jordan Veronica Gh Buy 1,268 11.83 15,000
2006-06-09 Frost Mark T (Chief Financial Officer) Buy 2,500 10.45 26,125
2005-05-18 Tartaglia Anthony P Buy 1,687 11.85 19,990
2005-05-18 Oconnor Kevin Buy 1,687 11.85 19,990
2005-05-18 Anderson Paul S Buy 843 11.85 9,989
2005-05-18 Kuhla Donald E (Executive Vice Presi) Buy 1,687 11.85 19,990
2005-03-17 D Ambra Thomas E Phd (President) Buy 27,400 8.99 246,326
2005-03-17 D Ambra Constance M Buy 27,400 8.99 246,326
2005-03-15 D Ambra Thomas E Phd (President) Buy 45,522 9.00 409,698
2005-03-15 D Ambra Constance M Buy 45,522 9.00 409,698
2005-03-14 Frost Mark T (Chief Financial Officer) Buy 5,000 8.64 43,200
2005-03-14 D Ambra Thomas E Phd (President) Buy 21,591 8.78 189,568
2005-03-14 D Ambra Constance M Buy 21,591 8.78 189,568
2005-03-11 Frost Mark T (Chief Financial Officer) Buy 10,000 .00 0
2005-03-11 D Ambra Thomas E Phd (President) Buy 44,307 8.43 373,508
2005-03-11 D Ambra Constance M Buy 44,307 8.43 373,508
2005-03-10 D Ambra Thomas E Phd (President) Buy 44,307 8.32 368,634
2005-03-10 D Ambra Constance M Buy 44,307 8.32 368,634
2005-03-09 D Ambra Thomas E Phd (President) Buy 24,970 8.15 203,505
2005-03-09 D Ambra Constance M Buy 24,970 8.15 203,505
2005-03-08 Roth Arthur J Buy 5,000 8.32 41,600
2005-03-08 D Ambra Thomas E Phd (President) Buy 36,336 8.19 297,591
2005-03-08 D Ambra Constance M Buy 36,336 8.19 297,591

Insider trading activities including stock purchases, stock sales, and option exercises of AMRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Albany Molecular Research Inc (symbol AMRI, CIK number 1065087) see the Securities and Exchange Commission (SEC) website.